200 related articles for article (PubMed ID: 19075276)
1. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Papadimitrakopoulou VA; Lee JJ; William WN; Martin JW; Thomas M; Kim ES; Khuri FR; Shin DM; Feng L; Hong WK; Lippman SM
J Clin Oncol; 2009 Feb; 27(4):599-604. PubMed ID: 19075276
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.
Dimery IW; Hong WK; Lee JJ; Guillory-Perez C; Pham F; Fritsche HA; Lippman SM
Ann Oncol; 1997 Jan; 8(1):85-9. PubMed ID: 9093712
[TBL] [Abstract][Full Text] [Related]
3. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Saintigny P; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim ES; Hong WK; Lippman SM; Mao L
Clin Cancer Res; 2009 Oct; 15(19):6284-91. PubMed ID: 19773378
[TBL] [Abstract][Full Text] [Related]
4. No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene.
Ambrosini GL; Bremner AP; Reid A; Mackerras D; Alfonso H; Olsen NJ; Musk AW; de Klerk NH
Osteoporos Int; 2013 Apr; 24(4):1285-93. PubMed ID: 22986930
[TBL] [Abstract][Full Text] [Related]
5. Positive impact of retinyl palmitate in leukoplakia of the larynx.
Issing WJ; Struck R; Naumann A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S105-9. PubMed ID: 9065641
[TBL] [Abstract][Full Text] [Related]
6. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men.
Maserejian NN; Giovannucci E; Rosner B; Joshipura K
Int J Cancer; 2007 Mar; 120(5):970-7. PubMed ID: 17163413
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment.
Sankaranarayanan R; Mathew B; Varghese C; Sudhakaran PR; Menon V; Jayadeep A; Nair MK; Mathews C; Mahalingam TR; Balaram P; Nair PP
Oral Oncol; 1997 Jul; 33(4):231-6. PubMed ID: 9307711
[TBL] [Abstract][Full Text] [Related]
10. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.
van Zandwijk N; Dalesio O; Pastorino U; de Vries N; van Tinteren H
J Natl Cancer Inst; 2000 Jun; 92(12):977-86. PubMed ID: 10861309
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer.
Zaridze D; Evstifeeva T; Boyle P
Ann Epidemiol; 1993 May; 3(3):225-34. PubMed ID: 8275193
[TBL] [Abstract][Full Text] [Related]
12. Single oral dose of micellar β-carotene containing phospholipids improves β-carotene metabolism and plasma lipids in vitamin A-deficient rats.
Marisiddaiah R; Rangaswamy L; Vallikannan B
Eur J Nutr; 2011 Oct; 50(7):531-41. PubMed ID: 21188595
[TBL] [Abstract][Full Text] [Related]
13. Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate.
Sedjo RL; Ranger-Moore J; Foote J; Craft NE; Alberts DS; Xu MJ; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1687-92. PubMed ID: 15533894
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of oral cancer in leukoplakia patients: A systematic review and meta-analysis.
Xie A; Liu J
J Pak Med Assoc; 2017 Sep; 67(9):1415-1419. PubMed ID: 28924285
[TBL] [Abstract][Full Text] [Related]
15. Retinoids and chemoprevention: clinical and basic studies.
Lippman SM; Heyman RA; Kurie JM; Benner SE; Hong WK
J Cell Biochem Suppl; 1995; 22():1-10. PubMed ID: 8538183
[TBL] [Abstract][Full Text] [Related]
16. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia].
Issing WJ; Struck R; Naumann A; Kastenbauer E
Laryngorhinootologie; 1996 Jan; 75(1):29-33. PubMed ID: 8851116
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
William WN; Papadimitrakopoulou V; Lee JJ; Mao L; Cohen EE; Lin HY; Gillenwater AM; Martin JW; Lingen MW; Boyle JO; Shin DM; Vigneswaran N; Shinn N; Heymach JV; Wistuba II; Tang X; Kim ES; Saintigny P; Blair EA; Meiller T; Gutkind JS; Myers J; El-Naggar A; Lippman SM
JAMA Oncol; 2016 Feb; 2(2):209-16. PubMed ID: 26540028
[TBL] [Abstract][Full Text] [Related]
18. Canthaxanthin and excess vitamin A alter alpha-tocopherol, carotenoid and iron status in adult rats.
Blakely SR; Mitchell GV; Jenkins MY; Grundel E; Whittaker P
J Nutr; 1991 Oct; 121(10):1649-55. PubMed ID: 1765831
[TBL] [Abstract][Full Text] [Related]
19. Prevention of lung cancer.
Goodman GE
Crit Rev Oncol Hematol; 2000 Mar; 33(3):187-97. PubMed ID: 10789492
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial.
West KP; Christian P; Labrique AB; Rashid M; Shamim AA; Klemm RD; Massie AB; Mehra S; Schulze KJ; Ali H; Ullah B; Wu LS; Katz J; Banu H; Akhter HH; Sommer A
JAMA; 2011 May; 305(19):1986-95. PubMed ID: 21586714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
